| P50 | author | Georg A Petroianu | Q71158735 |
| P2093 | author name string | Dietrich E Lorke | |
| | Anka Stegmeier-Petroianu | |
| P2860 | cites work | The global distribution of fatal pesticide self-poisoning: systematic review | Q21257222 |
| | Organophosphorus ester-induced delayed neurotoxicity | Q23917267 |
| | Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex | Q24321349 |
| | The initial clinical trial of nitrogen mustard | Q28189888 |
| | Biochemistry, biology, and pharmacology of cyclic adenosine diphosphoribose (cADPR) | Q28255928 |
| | Thirteen-year follow-up of patients with tri-ortho-cresyl phosphate poisoning in northern suburbs of Xi'an in China | Q33478100 |
| | Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. | Q33753311 |
| | The tetrahydropyranopterin structure of the sulfur-free and metal-free molybdenum cofactor precursor | Q34294783 |
| | Rescue of lethal molybdenum cofactor deficiency by a biosynthetic precursor from Escherichia coli | Q34317217 |
| | Beta-lactamase-inhibitor combinations in the 21st century: current agents and new developments | Q34476139 |
| | Cholinergic and inhibitory synapses in a pathway from motor-axon collaterals to motoneurones | Q34537741 |
| | Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders | Q34624766 |
| | Identification of a Mutation in Porcine Ryanodine Receptor Associated with Malignant Hyperthermia | Q34795568 |
| | Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine | Q35004972 |
| | Cyclophosphamide and cancer: golden anniversary | Q35005506 |
| | Interactions between calcium release pathways: multiple messengers and multiple stores. | Q35051277 |
| | Antiviral efficacy upon administration of a HepDirect prodrug of 2'-C-methylcytidine to hepatitis C virus-infected chimpanzees | Q35139479 |
| | Molecular mechanisms of lysophosphatidic acid action | Q35559631 |
| | Biology of LPA in health and disease | Q35844022 |
| | GABAA receptor-mediated neurotransmission: Not so simple after all. | Q35965725 |
| | STUDIES OF THE TRIAD : I. Structure of the Junction in Frog Twitch Fibers | Q36192081 |
| | New metabolically stabilized analogues of lysophosphatidic acid: agonists, antagonists and enzyme inhibitors | Q36295455 |
| | Synthesis and kinetic evaluation of cyclophostin and cyclipostins phosphonate analogs as selective and potent inhibitors of microbial lipases | Q36455458 |
| | Unequal efficacy of pyridinium oximes in acute organophosphate poisoning | Q36800759 |
| | The cyclic AMP signaling pathway: Exploring targets for successful drug discovery (Review). | Q36817378 |
| | Lysophosphatidic acid (LPA) and its receptors | Q37361117 |
| | A Phosphatidic Acid (PA) conveyor system of continuous intracellular transport from cell membrane to nucleus maintains EGF receptor homeostasis | Q37565019 |
| | When and why amino acids? | Q37613300 |
| | Roles and mechanisms of the CD38/cyclic adenosine diphosphate ribose/Ca(2+) signaling pathway | Q37617265 |
| | Phosphatidic acid in neuronal development: a node for membrane and cytoskeleton rearrangements | Q38238870 |
| | Dantrolene, a treatment for Alzheimer disease? | Q38304771 |
| | Role of GABA(B) receptors in learning and memory and neurological disorders | Q38713022 |
| | Molybdenum cofactor and human disease. | Q38800902 |
| | Cyclic phosphatidic acid induces G0/G1 arrest, inhibits AKT phosphorylation, and downregulates cyclin D1 expression in colorectal cancer cells. | Q38850029 |
| | The effect of cyclic phosphatidic acid on the proliferation and differentiation of mouse cerebellar granule precursor cells during cerebellar development | Q38884100 |
| | Tricresyl phosphates and cholinesterase | Q39236781 |
| | Design, synthesis, and evaluation of novel cyclic phosphates of 5-aminosalicylic acid as cytochrome p450-activated prodrugs. | Q39560250 |
| | 2′-Deoxy-2′-α-fluoro-2′-β-C-methyl 3′,5′-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: Discovery of PSI-352938 | Q39635791 |
| | Development of insecticidal cyclic phosphoryl compounds through chemical and biochemical approaches | Q40146514 |
| | Enzymatically activated cycloSal-d4T-monophosphates: The third generation of cycloSal-pronucleotides | Q40163823 |
| | A family of phospholipid autacoids: occurrence, metabolism and bioactions | Q40370635 |
| | Synthesis, hydrolysis and anti-EBV activity of a series of 3'-modified cycloSal-BVDUMP pronucleotides | Q40779733 |
| | Muscarinic receptor-mediated dual regulation of ADP-ribosyl cyclase in NG108-15 neuronal cell membranes | Q41066727 |
| | Growth factor-like action of phosphatidic acid | Q41472962 |
| | A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds | Q41824592 |
| | Rat hormone sensitive lipase inhibition by cyclipostins and their analogs. | Q41987575 |
| | Bicyclic phosphorus esters: high toxicity without cholinesterase inhibition | Q42232099 |
| | β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study | Q42983237 |
| | Cyclipostins, novel hormone-sensitive lipase inhibitors from Streptomyces sp. DSM 13381. II. Isolation, structure elucidation and biological properties. | Q44077796 |
| | Inhibition of beta-lactamases by monocyclic acyl phosph(on)ates | Q44309785 |
| | Attenuation by cyclic phosphatidic acid of peritoneal metastasis of azoxymethane-induced intestinal cancers in Wistar rats. | Q44834242 |
| | Tri-ortho-cresyl phosphate (TOCP) decreases the levels of cytoskeletal proteins in hen sciatic nerve | Q45012045 |
| | Salinipostins A-K, long-chain bicyclic phosphotriesters as a potent and selective antimalarial chemotype | Q46929088 |
| | Factor I and gamma-aminobutyric acid. | Q51329275 |
| | [Clinical proof is the decisive terrain. The history of alkylating agents]. | Q52933783 |
| | Molecular self-assembly of amphiphilic cyclic phosphoryl gemcitabine with different N-fatty acyl tails and enhanced anticancer effects of the self-assembled nanostructures. | Q53834017 |
| | Organophosphates⧸Nerve Agent Poisoning: Mechanism of Action, Diagnosis, Prophylaxis, And Treatment | Q54212458 |
| | Cyclic-disulfide-based prodrugs for cytosol-specific drug delivery. | Q54313275 |
| | Bicyclic phosphates increase the cyclic GMP level in rat cerebellum, presumably due to reduced GABA inhibition | Q56853460 |
| | Cyclophostin, acetylcholinesterase inhibitor from Streptomyces lavendulae | Q70499894 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13-22 | |
| P577 | publication date | 2016-09-09 | |
| P1433 | published in | Journal of Applied Toxicology | Q3186896 |
| P1476 | title | Biologic activity of cyclic and caged phosphates: a review | |
| P478 | volume | 37 | |